School of Medicine
Showing 41-53 of 53 Results
-
Michitaka Nakano
Basic Life Research Scientist, Medicine - Med/Hematology
BioI am a MD/PhD postdoctoral fellow and medical oncologist with a long-standing interest in translational cancer research. My long-term goal is to be a lab-based physician-scientist and independent academic researcher, translating basic cancer research, and mentoring next-generation scientists. My thesis work in Japan focused on cancer stem cell equilibrium by uniquely applying organoid culture as a method to elucidate cancer stem cell dynamics, which was awarded in Japanese Cancer Association. Along with the development of the field represented by success in T cell checkpoint, my interest gradually shifted to immune oncology while I examined numerous numbers of cancer patients as a medical oncology fellow. My postdoctoral fellowship at Calvin Kuo Lab in Stanford (2019-present) focuses on tumor immune microenvironment. Kuo lab developed a unique 3D air-liquid interface (ALI) organoid system that cultures tumors while preserving their endogenous infiltrating immune cells (T,B ,NK, Myeloid cells). My postdoctoral work will prove the significance of organoids as a translational tool to discover tumor-immune interaction by novel checkpoint inhibitors for immune cells, which can be broadly applicable to basic cancer biology, precision medicine, therapeutics validation and biomarker discovery.
-
Kouta Niizuma
Basic Life Research Scientist, Stem Cell Bio Regenerative Med Institute
BioI am a Research Scientist in Prof. Hiromitsu Nakauchi's laboratory at Stanford University. I obtained my PhD in Immunology from the University of Tsukuba, Japan. During my doctoral studies in Prof. Akira Shibuya's laboratory, I focused on the characterization of cell surface receptors expressed on immune cells. I successfully cloned a novel human immunoglobulin-like receptor, CD300H, and established a specific monoclonal antibody. My research demonstrated that CD300H is expressed on a subset of human monocytes and dendritic cells and plays a crucial role in enhancing inflammation by promoting the production of inflammatory cytokines and chemokines.
During my PhD, I also studied as a visiting scholar in Prof. Lewis L. Lanier's laboratory at UCSF, where I investigated the role of the activating receptor NKG2D on NK cells in viral immunity.
Since May 2018, I have been a member of the Nakauchi lab. My current research focuses on the development of new immunotherapies using myeloid cells derived from iPS cells, the generation of monoclonal antibodies, and hematopoietic stem cell biology. -
Sean Paul Spencer, MD,PhD
Instructor, Medicine - Gastroenterology & Hepatology
BioSean Spencer, MD,PhD is a Gastroenterologist and Physician Scientist at Stanford University working with Justin Sonennburg,PhD to uncover the role of dietary intake on the gut microbiome and mucosal immune system. Sean obtained his medical degree University of Pennsylvania, earning his PhD studying nutritional immunology with Yasmine Belkaid,PhD at the National Institutes of Health (NIH), after which he moved to Boston for residency training at Massachusetts General Hospital and completed his Gastroenterology training at Stanford University. Sean’s career goal is to study mechanisms by which dietary intake influences our microbiome and immune system to better understand and treat gastrointestinal disease.
-
Yonatan Winetraub
Instructor, Structural Biology
Current Research and Scholarly InterestsMy interests span non-invasive imaging for early cancer diagnosis and space exploration.
I'm focusing on utilizing Optical Coherence Tomography (OCT) and machine learning to create virtual histology tools to image cancer non invasively at a single cell resolution, allowing physicians to skip biopsy (read more about the research). Prior to my PhD at Stanford, I co-founded SpaceIL, a non-profit organization that launched the first private interplanetary robotic mission to the Moon launched 2019. -
Kelly H. Yoo, MD, PhD
Postdoctoral Scholar, Neurosurgery
BioDr. Kelly H. Yoo is a postdoctoral scholar in the Department of Neurosurgery at Stanford University, specializing in innovative therapeutic strategies for neurosurgical pathologies. She earned her M.D. and Ph.D. from Heidelberg University School of Medicine, where her doctoral research focused on combining CAR T cell immunotherapy with ibrutinib and a reactive oxygen species accelerator, PipFcB, for hematologic malignancies. Graduating in the top 1% of her class, Dr. Yoo was recruited early for her residency in neurosurgery, where she honed her expertise in the interdisciplinary application of combinatorial treatment strategies.
Building on the knowledge she gained during her doctoral training, she worked to integrate CAR T cell therapy with bevacizumab, temozolomide chemotherapy, and radiation therapy for neurosurgical patients with primary and recurrent glioblastoma. As part of the clinician-scientist track, Dr. Yoo has completed several certifications, including Good Clinical Practice, the Principal Investigators Course, the Clinical Trial Investigators Course, and the Munich Investigators Course. These experiences have equipped her to design translational research that effectively bridges the gap between bench and bedside.
Recognized as a top 0.1% resident by the Baden-Württemberg Medical Association for her exceptional clinical and research performance, Dr. Yoo joined the Department of Neurosurgery at Stanford University to advance her career through a postdoctoral fellowship. -
Mang Yu
BioDr. Yu is contributing to growing the School of Medicine’s portfolio of grants, especially those related to biomedical data science
https://orcid.org/0000-0003-3302-3180
